Replies to post #278850 on Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

1iftrue, the debate goes on re how to subsidize pharmas to do new antibiotics. The good news is that IPIX has a new type of anti-biotic that will:
(1) Not take a billion or so to get to market, maybe less than 100 million for an FDA 3, a sales force and related costs
(2) Can charge less amounts because of #1 above
(3) Is a new type of antibiotic so may have less resistance issues
(4) Can get on the market relatively quickly after the $100 moil or so is covered
(5) Does not appear to have significant side effect issues
(6) May be suitable as an injectable (my hunch, not supported by any research -- as yet)

[Giovanni]

The insurance companies will not pay for them.

So you use a progression.